Judge Katsas Gregory G 's Rulings on Bioequivalence For Complex Drugs

Explore Judge Katsas Gregory G 's 1 rulings on bioequivalence for complex drugs. AI-powered summaries and legal analysis.

1
Cases
1
Remanded

Courts

cadc (1)

Judge Katsas Gregory G 's Bioequivalence For Complex Drugs Opinions (1)

Vanda Pharmaceuticals, Inc. v. FDA

D.C. Circuit Vacates FDA Denial of Citizen Petition on Generic Drug Approval

D.C. Circuit · 2025-08-15 · Remanded · Impact: 75/100

Vanda Pharmaceuticals, Inc. v. FDA, decided by D.C. Circuit on August 15, 2025, resulted in a remanded outcome. The D.C. Circuit reviewed the FDA's denial of Vanda Pharmaceuticals' citizen petition se...

Frequently Asked Questions

Q: How many bioequivalence for complex drugs cases has Judge Katsas Gregory G decided?

CaseLawBrief tracks 1 bioequivalence for complex drugs cases decided by Judge Katsas Gregory G . The count updates as new opinions are published.

Q: What is Judge Katsas Gregory G 's ruling pattern on bioequivalence for complex drugs cases?

Based on tracked cases, outcomes include: Remanded: 1.

Q: Which courts has Judge Katsas Gregory G served on for bioequivalence for complex drugs cases?

Judge Katsas Gregory G has decided bioequivalence for complex drugs cases in: cadc.

Explore More

All Judge Katsas Gregory G Cases All Bioequivalence For Complex Drugs Cases All Judges All Topics Search